Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Merck Serono announces decision to continue the development of tecemotide in Stage III non-small cell lung cancer

Merck Serono, the biopharmaceutical division of Merck, has announced the decision to continue clinical development of its investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) under a new Phase III trial called START2 for patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC)…

Go to Source

Leave a Reply

News

Parkinson’s: Targeting new compound slows disease in rats

The results of a decade-long study are in: a new therapeutic target is found, and scientists manage to slow the progression of the disease in animals. Powered by WPeMatico

more >

Added to chemotherapy, this drug doubles lung cancer survival

Adding immunotherapy to chemotherapy doubled survival in a trial of metastatic nonsquamous non-small cell lung cancer lacking EGFR and ALK mutations. Powered by WPeMatico

more >

New drug halves previously untreatable migraine attacks

A new compound, called erenumab, was found to be successful in treating migraines for which other treatments had previously failed. Powered by WPeMatico

more >

Antidepressants: Do they really work?

The debate over whether antidepressants can really help to tackle depression has been rife. We take a closer look at the evidence. Powered by WPeMatico

more >

Can we trust results from early clinical trials?

A new analysis demonstrates that early clinical trials looking at new treatments are more likely to produce exaggerated results. Why could this be? Powered by WPeMatico

more >

Experimental stroke drug succeeds in preliminary trials

Following preliminary clinical trials, a new anti-stroke drug shows promise for improved treatment, rendering patients less prone to adverse effects. Powered by WPeMatico

more >